(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified generically as a benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-substituted-6-substituted-1,3,5-triazin-2-yl]amino]-, sodium salt (PMN P-98-1222) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section.
(1) The chemical substance identified generically as a benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-substituted-6-substituted-1,3,5-triazin-2-yl]amino]-, sodium salt (PMN P-98-1222) is subject to reporting under this section for the significant new use described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80 (v)(1), (v)(2), (w)(1), (w)(2), (x)(1), and (x)(2).
(ii) [Reserved]
(b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.
(1) Recordkeeping. Recordkeeping requirements as specified in Sec. 721.125 (a), (b), (c), and (i) are applicable to manufacturers, importers, and processors of this substance.
(2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this section. [65 FR 374, Jan. 5, 2000] Sec. 721.9800 1,3,5-Triazine, 2,4,6-trichloro-, polymer with piperazine, reaction products with morpholine.
(a) Chemical substance and significant new uses subject to reporting. (1) The chemical substance identified as 1,3,5-triazine, 2,4,6-trichloro-, polymer with piperazine, reaction products with morpholine (PMN P-88-0436; CAS No. 1078142-02-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(1) The chemical substance identified as 1,3,5-triazine, 2,4,6-trichloro-, polymer with piperazine, reaction products with morpholine (PMN P-88-0436; CAS No. 1078142-02-5) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Hazard communication program. Requirements as specified in Sec. 721.72 (b)(2), (c), (e) (concentration set at 1.0 percent), (f), (g)(1) (statement-health effects not fully determined), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), and (g)(5). The requirements of this paragraph shall not apply when the PMN substance is encapsulated in a polymeric matrix.
(1) (statement-health effects not fully determined), (g)(2)(i), (g)(2)(ii), (g)(2)(iii), and (g)(5). The requirements of this paragraph shall not apply when the PMN substance is encapsulated in a polymeric matrix.
(i), (g)(2)(ii), (g)(2)(iii), and (g)(5). The requirements of this paragraph shall not apply when the PMN substance is encapsulated in a polymeric matrix.
(ii) Industrial, commercial, and consumer activities. Requirements as specified in Sec. 721.80(q).
(b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.
(1) Recordkeeping. The following recordkeeping requirements are applicable to manufacturers, importers, and processors of this substance, as specified in Sec. 721.125 (a) through (c), (g), and (h).
(2) Limitations or revocation of certain notification requirements. The provisions of Sec. 721.185 apply to this significant new use rule.
(3) Determining whether a specific use is subject to this section. The provisions of Sec. 721.1725(b)(1) apply to this section. [55 FR 32419, Aug. 9, 1990. Redesignated and amended at 58 FR 29946, 29947, May 24, 1993; 58 FR 34204, June 23, 1993; 63 FR 45956, Aug. 28, 1998; 79 FR 34638, June 18, 2014]